Grace Stockwell, Nicholas R Hoeh, Francesca Fogarty, Cerys Clayden, Lisa Reynolds
{"title":"了解氯胺酮辅助治疗的经验和环境的重要性。","authors":"Grace Stockwell, Nicholas R Hoeh, Francesca Fogarty, Cerys Clayden, Lisa Reynolds","doi":"10.1080/02791072.2025.2527299","DOIUrl":null,"url":null,"abstract":"<p><p>Ketamine-assisted therapy (KAT) is a novel modality that shows promise as a treatment for depression. The current study sought to add to the scarce research in the area and inform future applications of KAT for patients with treatment-resistant depression. The study used in-depth qualitative interviews (<i>N</i> = 12) to explore participants' perceptions of KAT, including working with therapists, the ketamine experience, the therapeutic setting, and how these aspects impacted experiences and their lives following treatment. Thematic analysis indicated that preparation of mind-set supported therapeutic benefit, which was underscored by openness, clear therapeutic intentions, mindfulness, and understanding the mechanisms of how KAT works. Additionally, comfort in the setting supported participants to \"let go\" and was facilitated by learning about the therapist's personal experiences, a strong therapeutic alliance, and feeling safe. External physical cues such as music also influenced the experience, facilitating a spiritual journey guiding the experience. Words of caution were expressed where trauma had been unveiled and letting go had left participants feeling vulnerable. These findings provide a deeper understanding of the impact of contextual processes during KAT to inform future clinical trials and improve the clinical efficacy of KAT.</p>","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"1-11"},"PeriodicalIF":2.2000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context.\",\"authors\":\"Grace Stockwell, Nicholas R Hoeh, Francesca Fogarty, Cerys Clayden, Lisa Reynolds\",\"doi\":\"10.1080/02791072.2025.2527299\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Ketamine-assisted therapy (KAT) is a novel modality that shows promise as a treatment for depression. The current study sought to add to the scarce research in the area and inform future applications of KAT for patients with treatment-resistant depression. The study used in-depth qualitative interviews (<i>N</i> = 12) to explore participants' perceptions of KAT, including working with therapists, the ketamine experience, the therapeutic setting, and how these aspects impacted experiences and their lives following treatment. Thematic analysis indicated that preparation of mind-set supported therapeutic benefit, which was underscored by openness, clear therapeutic intentions, mindfulness, and understanding the mechanisms of how KAT works. Additionally, comfort in the setting supported participants to \\\"let go\\\" and was facilitated by learning about the therapist's personal experiences, a strong therapeutic alliance, and feeling safe. External physical cues such as music also influenced the experience, facilitating a spiritual journey guiding the experience. Words of caution were expressed where trauma had been unveiled and letting go had left participants feeling vulnerable. These findings provide a deeper understanding of the impact of contextual processes during KAT to inform future clinical trials and improve the clinical efficacy of KAT.</p>\",\"PeriodicalId\":16902,\"journal\":{\"name\":\"Journal of psychoactive drugs\",\"volume\":\" \",\"pages\":\"1-11\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of psychoactive drugs\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/02791072.2025.2527299\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHOLOGY, CLINICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of psychoactive drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/02791072.2025.2527299","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context.
Ketamine-assisted therapy (KAT) is a novel modality that shows promise as a treatment for depression. The current study sought to add to the scarce research in the area and inform future applications of KAT for patients with treatment-resistant depression. The study used in-depth qualitative interviews (N = 12) to explore participants' perceptions of KAT, including working with therapists, the ketamine experience, the therapeutic setting, and how these aspects impacted experiences and their lives following treatment. Thematic analysis indicated that preparation of mind-set supported therapeutic benefit, which was underscored by openness, clear therapeutic intentions, mindfulness, and understanding the mechanisms of how KAT works. Additionally, comfort in the setting supported participants to "let go" and was facilitated by learning about the therapist's personal experiences, a strong therapeutic alliance, and feeling safe. External physical cues such as music also influenced the experience, facilitating a spiritual journey guiding the experience. Words of caution were expressed where trauma had been unveiled and letting go had left participants feeling vulnerable. These findings provide a deeper understanding of the impact of contextual processes during KAT to inform future clinical trials and improve the clinical efficacy of KAT.